H. G. Barsumian Memorial Fund Report issue

Foundation

Organization Overview

First Clinical Trial
2011
NCT01330589
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2011

Timeline

NOW
  • Now

Active Ingredients

Drugs in Other Trials (1)

hypericum perforatum (1 trial)

Indications

Overview

  • Highest Phase: Phase 0
  • # of Trials: 1
  • # of Trial APIs: 1